[(223)Ra] RaCl(2) nanomicelles showed potent effect against osteosarcoma: targeted alpha therapy in the nanotechnology era

The treatment of bone metastatsis as primary bone cancer itself is still a challenge. The use od radium dichloride ([(223)Ra] RaCl(2)) has emerged in the last few years as one of the best treatment choice for bone cancer, with especial focus in bone metastasis. The alpha-emitter radiopharmaceutical...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Yang, Alencar, Luciana Magalhães Rebelo, Pijeira, Martha Sahylí Ortega, Batista, Beatriz da Silva, França, Alefe Roger Silva, Rates, Erick Rafael Dias, Lima, Ruana Cardoso, Gemini-Piperni, Sara, Santos-Oliveira, Ralph
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8741223/
https://www.ncbi.nlm.nih.gov/pubmed/35191342
http://dx.doi.org/10.1080/10717544.2021.2005719

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8741223/
https://www.ncbi.nlm.nih.gov/pubmed/35191342
http://dx.doi.org/10.1080/10717544.2021.2005719

Ejemplares similares